Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PPARG Antibody | Login | PPARG Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKACA Antibody (Phospho-Ser338) | Login | PRKACA Antibody (Phospho-Ser338) | ||||||||||||||||
|
||||||||||||||||||
| PRKACA Antibody - N-terminal region | Login | PRKACA Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| PRKACA Antibody (Phospho-Thr198) | Login | PRKACA Antibody (Phospho-Thr198) | ||||||||||||||||
|
||||||||||||||||||
| SPTAN1 Antibody (Cleaved-Asp1185) | Login | SPTAN1 Antibody (Cleaved-Asp1185) | ||||||||||||||||
|
||||||||||||||||||
| PRKAR2A Antibody - middle region | Login | PRKAR2A Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| PRKCA Antibody (Phospho-Tyr657) | Login | PRKCA Antibody (Phospho-Tyr657) | ||||||||||||||||
|
||||||||||||||||||
| PRKCD Antibody (Phospho-Tyr64) | Login | PRKCD Antibody (Phospho-Tyr64) | ||||||||||||||||
|
||||||||||||||||||
| STAT1 Antibody | Login | STAT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT1 Antibody | Login | STAT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT2 Antibody (Phospho-Tyr690) | Login | STAT2 Antibody (Phospho-Tyr690) | ||||||||||||||||
|
||||||||||||||||||
| STAT2 Antibody (Phospho-Tyr631) | Login | STAT2 Antibody (Phospho-Tyr631) | ||||||||||||||||
|
||||||||||||||||||
| STAT2 Antibody | Login | STAT2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT2 Antibody | Login | STAT2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT2 Antibody | Login | STAT2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKCQ Antibody (Phospho-Ser695) | Login | PRKCQ Antibody (Phospho-Ser695) | ||||||||||||||||
|
||||||||||||||||||
| STAT3 Antibody | Login | STAT3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKCQ Antibody (Phospho-Ser676) | Login | PRKCQ Antibody (Phospho-Ser676) | ||||||||||||||||
|
||||||||||||||||||
| STAT4 Antibody (Phospho-Tyr693) | Login | STAT4 Antibody (Phospho-Tyr693) | ||||||||||||||||
|
||||||||||||||||||
| PRKCZ Antibody (Phospho-Thr560) | Login | PRKCZ Antibody (Phospho-Thr560) | ||||||||||||||||
|
||||||||||||||||||
| PRKCZ Antibody | Login | PRKCZ Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKCZ Antibody | Login | PRKCZ Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT5A Antibody - middle region | Login | STAT5A Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| STAT5A Antibody | Login | STAT5A Antibody | ||||||||||||||||
|
||||||||||||||||||
| STAT5B Antibody (Phospho-Ser726/731) | Login | STAT5B Antibody (Phospho-Ser726/731) | ||||||||||||||||
|
||||||||||||||||||


